Minutes to Answers: Compliant Chat Builds More Meaningful HCP Relationships
As therapies become more complex, field reps and doctors are finding new ways to create purposeful interactions in the time of need. The more complex…
As therapies become more complex, field reps and doctors are finding new ways to create purposeful interactions in the time of need. The more complex…
The European Commission recently unveiled two long-awaited proposals on digital services and digital markets. While we don’t yet know how—or when—these measures will be enacted,…
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
COVID-19 has changed how people work across continents, countries and sectors. In Europe, these changes may be irreversible. Research in the UK, for example, suggests…
The landscape of publication planning is constantly evolving with the rise of novel digital tools, artificial intelligence, and virtual collaboration platforms. As a result, traditional…
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
The days of cookie-cutter medical education sessions and unengaging, didactic data presentations are–mostly–over. These days, medical education and training programs are all about customization, personalization,…
Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Here, Alpharmaxim’s William Hind…
As trials become increasingly complex, companies share how leaving behind legacy EDC systems can save thousands of hours during study build and testing. In today’s…
Direct pharma-patient engagement used to be considered largely a “nice to have,” and was, at best, a rare occurrence at specific times during the pharmaceutical…